Affinite Instruments
Affinité Instruments designs and manufactures portable, patented lensless Surface Plasmon Resonance (SPR) instruments and consumables for label-free binding analysis, serving academic, biotech, and pharmaceutical researchers in 15+ countries.
- Company typePrivate
- Founded2015
- HeadquartersMontréal, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Affinite Instruments does
Affinité Instruments Inc., founded in 2015 and headquartered in Toronto, Canada, designs and manufactures portable Surface Plasmon Resonance (SPR) instruments for label-free binding analysis. Its platform is built on a patented lensless SPR architecture that eliminates conventional optics (lenses, prisms, precision alignment), enabling compact, lower-cost instruments that retain publication-quality kinetic data. The product portfolio spans the P4SPR 2.0 (ultra-compact 4-channel static SPR for rapid screening), the P4PRO (benchtop flow SPR with AffiPump for full kon/koff/KD kinetic characterization), AffiCoat proprietary zwitterionic peptide surface chemistry, disposable pre-characterized gold sensor chips and reagent kits, and the AffiLabs.core desktop software with embedded SPARQ in-device run quality diagnostics. The company sells directly to academic labs, biotech startups, pharma R&D groups, and biomanufacturing customers in 15+ countries, reaching 500+ researchers worldwide.
Revenue is generated primarily through one-time hardware sales of P4SPR and P4PRO instruments (quote-based pricing, no public list prices), a recurring consumables stream from single-use sensor chips and reagent kits, and a professional services tail via the Affibio SPR-as-a-service offering, which includes mobile SPR deployment to customer sites. Go-to-market is consultative and direct-to-customer, supported by 80+ peer-reviewed publications validating the platform, content marketing through application notes and a resource library, conference presence (e.g., PEGS 2025), and global lab visits. The company was built entirely on non-dilutive funding and remains privately held under founder control, with no institutional venture capital or PE investment disclosed. Key strategic partnerships include ongoing collaboration with Université de Montréal (origin of the technology) and the CERVO Brain Research Center for SPR-based AAV gene therapy quality control.
Affinite Instruments firmographics
Firmographics- Name
- Affinite Instruments
- Legal name
- Affinité Instruments Inc.
- Website
- https://affiniteinstruments.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Affinité Instruments designs and manufactures portable, patented lensless Surface Plasmon Resonance (SPR) instruments and consumables for label-free binding analysis, serving academic, biotech, and pharmaceutical researchers in 15+ countries.
- Ownership category
- akta.pro rank
Where Affinite Instruments is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Affinite Instruments business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure
Revenue model
- SPR Instruments: Sale of P4SPR 2.0 (static SPR) and P4PRO (benchtop flow SPR) instruments. Instruments are compact, laptop-powered where applicable, and sold directly via quote requests.
- Sensors and Consumables: Disposable gold sensor chips with various surface chemistries (Carboxyl, CMD, AffiCoat, NTA, Streptavidin, Protein A/G, etc.) and reagent kits (amine coupling, NTA, SA, IgG capture, immobilization scouting). Sensors are pre-characterized, single-use to avoid carry-over.
- Software (AffiLabs.core): Desktop software application included with instrument purchase. Software provides instrument control, data acquisition, kinetic analysis, and IQ/OQ validation. P4SPR 2.0 hardware upgrade available for existing owners with improved SNR and expanded surface sensor library access.
- Affibio Service (SPR as a Service): Expert-run SPR experiments delivered to customers who need results without owning an instrument. Full characterization and scientific collaboration offered. Mobile SPR service brings the instrument to customer facilities for on-site testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | P4SPR 2.0 — Static SPR instrument for rapid screening and assay development |
| One time/ perpetual license | Pay-as-you-go | P4PRO — Benchtop flow SPR for full kinetic characterization |
| Unit Pricing | Pay-as-you-go | Sensors and Reagent Kits |
| One time/ perpetual license | Pay-as-you-go | AffiLabs.core Software Upgrade — P4SPR 2.0 |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Affinite Instruments product offering
Product offeringCore offering
Affinité Instruments designs, manufactures, and sells patented lensless Surface Plasmon Resonance (SPR) instruments — the laptop-powered P4SPR 2.0 for static screening and the benchtop P4PRO with AffiPump for kinetic characterization — together with the AffiLabs.core software, SPARQ embedded run-quality diagnostics, proprietary AffiCoat surface chemistry, disposable gold sensor chips, reagent kits, and Affibio SPR-as-a-Service contract analysis. The integrated platform serves academic, biotech, pharma R&D, and biomanufacturing customers.
Product overview
Affinité Instruments offers a complete SPR (Surface Plasmon Resonance) platform centered on its patented lensless optical architecture. The product portfolio spans two complementary SPR instruments — the P4SPR 2.0 for portable static screening and the P4PRO with AffiPump for full kinetic characterization — supported by proprietary surface chemistries (Afficoat), disposable gold sensor chips and reagent kits, and a unified software ecosystem (AffiLabs.core). Embedded intelligence is provided by SPARQ (in-device run quality diagnostics) and extended by Sparq Bio (cloud AI platform, coming soon). SPR-as-a-service is available through Affibio. The platform is designed as an integrated ecosystem — instrument, microfluidics, consumables, software, and intelligence layer — co-engineered to work as one.
Differentiator
Problem solved
Functional benefit
Products and services
- P4SPR 2.0 Ultra-compact, 4-channel, laptop-powered static Surface Plasmon Resonance instrument for rapid yes/no binding screening, concentration estimation in complex or crude media, and assay development; fM detection limit, 150 µL sample volume, and ≤10 min per cycle. Targeted at academic, biotech, and pharma research labs needing portable label-free binding analysis.
- P4PRO Benchtop 4-channel hybrid static/flow SPR system paired with AffiPump for full kinetic characterization (kon 10^3–10^7 M^−1s^−1, koff 10^−5–10^−1 s^−1, KD), with semi-automated injection and 5–100 µL flow injection volume. Targeted at researchers needing publishable kinetic data without core-facility access.
- AffiLabs.core Desktop application for P4SPR and P4PRO instrument control, data acquisition, kinetic and steady-state fitting, leak/bubble detection, ML-powered LED calibration, one-click Excel/CSV export, and IQ/OQ validation (12 automated IQ checks, 43 OQ tests across 6 suites). Targeted at P4SPR and P4PRO users needing compliant, software-driven experimental control and analysis.
- AffiPump Precision peristaltic flow-control accessory for the P4PRO providing stable, controlled flow (0.3–10,000 µL/min) for clean association and dissociation phases in kinetic SPR experiments. Targeted at P4PRO users needing precise kinetic measurements.
- AffiCoat surface chemistry Proprietary zwitterionic peptide self-assembled monolayer for gold SPR sensors that minimizes non-specific adsorption in serum, plasma, and cell lysate, enabling covalent capture-molecule immobilization while preserving enzyme activity. Targeted at SPR users running assays in crude biological matrices.
- Sensors and Reagent Kits Disposable pre-characterized gold sensor chips (Carboxyl, CMD, AffiCoat, Anti-His, NTA, Protein A/G, Streptavidin, Strep-Tactin XT, Anti-AAVX) sold alongside reagent kits including Amine Coupling, NTA, SA, IgG Capture, and Immobilization Scouting kits. Targeted at Affinité SPR instrument users needing validated consumables.
- Affibio (SPR-as-a-Service) SPR expertise-as-a-service offering expert-run experiments, validated methods, and full kinetic characterization, including mobile SPR deployment to customer sites. Targeted at biopharma and biotech programs that need binding data without purchasing an instrument.
Quantifiable outcome
- 5 minutes per SPR run, enabling 20+ conditions screened in under 2 hours
- +4 more outcomes
Companies that use Affinite Instruments
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles2 records
Affinite Instruments technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
Affinite Instruments partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Université de MontréalcoreAffinité Instruments originated from Jean-François Masson's research group at Université de Montréal. The platform's lensless SPR technology and AffiCoat surface chemistry derive from university research. Co-founders include Full Professors of Chemistry from Université de Montréal (Jean-François Masson and Joelle Pelletier). Ongoing research collaboration and academic publications continue.
- CERVO Brain Research CentercoreCollaboration with CERVO Brain Research Center to apply SPR protocols to AAV gene therapy vector quality control. Goal to enable smaller labs and facilities to participate in gene therapy research using viral vectors. Part of broader effort to integrate SPR into AAV production pipelines.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Affinite Instruments competitors and assessment
Company assessmentBroad incumbents
- Cytiva (Biacore): Global life sciences tools giant (Danaher subsidiary) and the dominant SPR platform vendor via its Biacore line. Directly comparable as the established gold-standard SPR instrument competitor that Affinité's lensless architecture is positioned against on cost and portability.
- Bruker (incl. Dynamic Biosensors): Scientific instruments major that acquired Dynamic Biosensors GmbH in October 2024 to expand its SPR/biosensor portfolio. Directly comparable as a large, capital-rich incumbent competing in the same SPR and biophysical-instrument category.
- Bio-Rad Laboratories (ProteOn): Major life sciences tools provider that previously commercialized the ProteOn SPR platform. Comparable as a broad incumbent with historical SPR/binding-analysis product overlap, though Bio-Rad has reduced its SPR focus.
- HORIBA Scientific: Scientific instruments provider with biosensor and analytical instrument capabilities serving life sciences and materials research. Comparable as a broad incumbent with overlapping label-free analytical measurement products.
Direct peers
- Carterra: Developer of the LSA XT high-throughput SPR platform for antibody and biologics characterization. Directly comparable as a specialist SPR instrument peer serving pharma and biotech customers with overlapping kinetic and affinity applications.
- Attana: Swedish company building label-free biosensor instruments and cell-based interaction analysis tools for life science research. Directly comparable as a focused, niche SPR/biosensor instrument peer serving drug discovery and diagnostics.
- Reichert Technologies: Manufacturer of SPR instruments and surface plasmon resonance analytical systems serving research and life science markets. Directly comparable as a specialized SPR instrument peer with overlapping kinetic characterization applications.
- Biosensing Instrument (BI): Specialized SPR instrument maker focused on high-sensitivity kinetic and binding interaction analysis for research and drug discovery. Directly comparable as a niche SPR peer competing in the same label-free binding analysis market.
- Nicoya (Alto): Canadian developer of benchtop, digital-SPR instruments (Alto) targeted at biologics and drug discovery researchers. Directly comparable as a focused SPR instrument peer with a similar portable, accessible-instrument value proposition.
Emerging players
- XanTec Bioanalytics: Provider of SPR sensor chips, surface chemistries, and reagents for SPR instruments. Comparable as a focused consumables and surface-chemistry player in the same SPR ecosystem where Affinité monetizes AffiCoat and sensor chips.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Affinite Instruments social profiles
Digital presenceAffinite Instruments financial estimates
Financial estimateRevenue estimate
Valuation estimate
Affinite Instruments leadership team
Management profileNumber of profiles
Profiles6 records
Affinite Instruments funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Affinite Instruments M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Affinite Instruments
What does Affinite Instruments do?
Affinité Instruments designs, manufactures, and sells patented lensless Surface Plasmon Resonance (SPR) instruments — the laptop-powered P4SPR 2.0 for static screening and the benchtop P4PRO with AffiPump for kinetic characterization — together with the AffiLabs.core software, SPARQ embedded run-quality diagnostics, proprietary AffiCoat surface chemistry, disposable gold sensor chips, reagent kits, and Affibio SPR-as-a-Service contract analysis. The integrated platform serves academic, biotech, pharma R&D, and biomanufacturing customers.
Is Affinite Instruments a public or private company?
Affinite Instruments is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Affinite Instruments founded?
Affinite Instruments was founded in 2015. It employs 1 to 10 people.
Where is Affinite Instruments based?
Affinite Instruments is headquartered in Montréal, Canada, in the North America region.
How does Affinite Instruments make money?
Four revenue lines are on record. SPR Instruments are the primary driver. The others are sensors and Consumables, software (AffiLabs.core) and affibio Service (SPR as a Service).
Who are Affinite Instruments's main competitors?
Broad incumbents on record are Cytiva (Biacore), Bruker (incl. Dynamic Biosensors), Bio-Rad Laboratories (ProteOn) and HORIBA Scientific. Direct peers are Carterra, Attana, Reichert Technologies, Biosensing Instrument (BI) and Nicoya (Alto). XanTec Bioanalytics is listed as an emerging player.
Does Affinite Instruments have an API?
No public API is recorded for Affinite Instruments.